首页> 美国卫生研究院文献>Infection and Immunity >Note: Development of a Competitive Index Assay To Evaluate the Virulence of Listeria monocytogenes actA Mutants during Primary and Secondary Infection of Mice
【2h】

Note: Development of a Competitive Index Assay To Evaluate the Virulence of Listeria monocytogenes actA Mutants during Primary and Secondary Infection of Mice

机译:注意:竞争性指数分析方法的开发以评估在小鼠的初次和二次感染中李斯特菌李斯特菌actA突变体的毒力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We developed a competitive index assay for murine listeriosis that tests the virulence of Listeria monocytogenes strains in different organs and at various times postinoculation. Studies presented here demonstrate the reproducibility of this assay during primary and secondary infection of inbred and outbred mice. We verified the validity of this assay by performing competitive index analysis of a well-characterized strain of L. monocytogenes lacking the actA gene. In addition, we found that while L. monocytogenes strains unable to recruit vasodilator-stimulated phosphoprotein (VASP) to their surface exhibit a 10-fold virulence attenuation in the livers of naive animals, they display a 50-fold survival defect in the liver during secondary listeriosis.
机译:我们开发了一种针对鼠李斯特氏菌病的竞争性指标测定法,可测试接种后不同时间不同器官中单核细胞增生李斯特菌菌株的毒力。本文介绍的研究表明,该方法在近交和近交小鼠的初次和继发感染过程中具有可重复性。我们通过对缺乏actA基因的单核细胞增生李斯特菌菌株进行竞争性指数分析,验证了该测定的有效性。此外,我们发现,虽然单核细胞增生李斯特氏菌菌株无法将血管扩张剂刺激的磷蛋白(VASP)募集到它们的表面,在幼稚动物的肝脏中显示出10倍的毒力减弱,但在感染期间它们在肝脏中表现出50倍的生存缺陷继发性李斯特菌病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号